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ER–Golgi networkThe humanmalaria parasite Plasmodium falciparum possesses sophisticated systems of protein secretion tomod-
ulate host cell invasion and remodeling. In the present study, we provide insights into the function of the AP-1
complex in P. falciparum. We utilized GFP fusion constructs for live cell imaging, as well as fixed parasites in im-
munofluorescence analysis, to study adaptor protein mu1 (Pfμ1) mediated protein trafficking in P. falciparum. In
trophozoites Pfμ1 showed similar dynamic localization to that of several Golgi/ER markers, indicating Golgi/ER
localization. Treatment of transgenic parasites with Brefeldin A altered the localization of Golgi-associated
Pfμ1, supporting the localization studies. Co-localization studies showed considerable overlap of Pfμ1 with the
resident rhoptry proteins, rhoptry associated protein 1 (RAP1) and Cytoadherence linked asexual gene 3.1
(Clag3.1) in schizont stage. Immunoprecipitation experiments with Pfμ1 and PfRAP1 revealed an interaction,
which may be mediated through an intermediate transmembrane cargo receptor. A specific role for Pfμ1 in traf-
ficking was suggested by treatment with AlF4, which resulted in a shift to a predominantly ER-associated com-
partment and consequent decrease in co-localization with the Golgi marker GRASP. Together, these results
suggest a role for the AP-1 complex in rhoptry protein trafficking in P. falciparum.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Despite increased preventative measures and renewed interest in
the eradication of malaria, global mortality has been estimated at 1.2
million in 2010 [1]. Though five species cause infections in humans,
Plasmodium falciparum can induce lethal cerebral malaria and is associ-
ated with the highest mortality rates. Plasmodium belongs to a phylum
of obligate intracellular parasites known as the Apicomplexa, that also in-
cludes such prolific organisms as Toxoplasma gondii and Cryptosporidium
spp. The phylum is so named because of the apical complex, a sophisticat-
ed cytoskeletal structure located at the apical end of the cell, and the
associated organelles; micronemes and rhoptries. Discharge of these
organelles, as well as the non apically localized dense granules, assists in
all stages of host cell invasion and remodeling, and they are essential ford@icgeb.res.in (A. Mohmmed),
Genetic Engineering, Mawlana
gail-1902, Bangladesh.
0014, Bihar, India.parasite viability [2].Micronemes and rhoptries likely represent highly di-
vergent endolysosomal organelles [3,4], but they are distinct in terms of
morphology and protein content. Assuming this relationship to be true,
trafficking to apical organelles should bear similarities to that of
endosomes and lysosomes in model systems.
Recent studies in T. gondii have deciphered some of the machinery
involved in trafficking to apical organelles (reviewed in [5]). Early stud-
ies noted the existence of an intermediate compartment in the traffick-
ing of micronemal proteins [6], which was subsequently shown to be
an endosome-like compartment for the removal of microneme pro-
peptides [7]. Rhoptry and microneme biogenesis in T. gondii occur
from the fusion of post-Golgi vesicles, whose scission is likely regulated
by a dynamin related protein (DrpB). Ablation of DrpB in T. gondii
results in the absence of distinct micronemes and rhoptries [8]. Rab
GTPases, specifically Rab5a and 5c, are involved in targeting at least a
subset of micronemal and rhoptry proteins [9]. Additionally, for soluble
rhoptry and microneme contents, transmembrane receptors such as
TgSORTLR are required for appropriate targeting [10]. The current
paradigm seems to be a re-purposing of trafficking pathways tradition-
ally involved in endocytic processes to facilitate trafficking to the secre-
tory organelles (reviewed in [11]). This still needs to be verified in
P. falciparum, as it appears that micronemes and rhoptries may form
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compartment was just described [15], and the mechanisms governing
similar processes in other Apicomplexa remain unclear as well.
One set of potentially important machinery that has not been investi-
gated thoroughly to date in P. falciparum is the adaptor protein (AP)
complexes.
Five such adaptor protein complexes exist, and are involved in cargo
recognition in the formation of post-Golgi trafficking vesicles [16]. AP-1
and AP-2 interact with the scaffolding protein clathrin, while AP-4 and
AP-5 do not; the interaction of AP-3 with clathrin remains uncertain
[17]. In mammalian cells, AP-1 is involved in trafficking between the
TGN and endosomes, AP-2 is involved in clathrin-mediated endoyctosis
at the plasma membrane, and AP-3 is involved in trafficking to lyso-
somes and lysosome-related organelles (reviewed in [18,19]). The
more recently discovered AP-4 and AP-5 do not have well-defined
roles, but appear to play a role in endosomal trafficking of specific
cargoes [17,20]. APs are heterotetrameric complexes composed of two
large (γ, α, δ, ε, ζ, and β1–5), one medium (μ1–5), and one small
(σ1–5) subunit. Large subunits are involved in binding to the target
membrane and mediating interactions with clathrin and other cargo
adaptors [18]. The small subunits are thought to be involved in complex
stability [21], and also form binding interfaces for dileucine-based cargo
motifs [22]. Medium subunits are involved in the recognition of trans-
membrane cargo adaptors by binding to specific motifs in their cyto-
plasmic tail, notably the canonical YXXphi motif [23].
A previous bioinformatic study identified components of the AP-1–4
complexes in the genomes of Plasmodium spp. and T. gondii [24]. How-
ever, while T. gondii was reported to possess the recently described
AP-5 complex, P. falciparum did not [16]. Though AP-3 is involved in
trafficking to lysosomes and LROs [25], it is not present in Theileria,
Babesia, or Cryptosporidium, and hence is a less attractive candidate for
trafficking to micronemes and rhoptries. AP-1 was previously implicat-
ed in trafficking to the rhoptries in T. gondii. The authors demonstrated
localization of Tgμ1 to the Golgi, endosome like compartment, and to
maturing and mature rhoptries utilizing both immunofluorescence
and electron microscopy [26]. Additionally, the authors showed that a
D176A mutation, predicted to alter binding to the YXXphi motif, alters
rhoptry morphology and arrests ROP2 trafficking in intermediate
endosomal compartments [26]. However, their additional suggestion
that Tgμ1 interacts directly with the C-terminal, cytoplasmic, portion
of the rhoptry bulb protein ROP2 was subsequently discredited by
the lack of a transmembrane domain in its structure, and the subse-
quent finding of association with membranes being mediated through
N-terminal amphipathic helices [27,28]. More recent studies suggest
that AP-1 in T. gondiimediates trafficking of at least a subset of apical or-
ganelle proteins through interactions with the sortilin-like receptor
TgSORTLR [10,15]. Consequently, the full extent and nature of AP-1
involvement in trafficking to invasion organelles in Apicomplexa are
unclear. This is hampered by the fact that this question has only been
examined in the model system of Toxoplasma. To address this gap on
the promising basis of the previous work in Toxoplasma and the role of
AP-1 in functionally homologous organelles in other eukaryotes, we
chose to investigate the role of AP-1 in protein trafficking to the apical
organelles in P. falciparum.
In the present work, we have cloned the μ subunit of AP-1 and
generated a Pfμ1–GFP transgenic parasite line to study Pfμ1 mediat-
ed vesicular transport processes. Our results show that Pfμ1 is asso-
ciated with the Golgi in early trophozoite stages, and co-localizes
with resident rhoptry proteins RAP1 and Clag3.1 in later asexual
stages, but not with the microneme marker EBA175, suggesting a
specific role in rhoptry trafficking. These results are further supported
by co-immunoprecipitation studies showing interaction between Pfμ1
and RAP1, and a substantial re-distribution of Pfμ1 upon AlF4 treatment,
which suggests a specific role for the complex in trafficking. Our results
suggest that the AP-1 complex is involved in trafficking to the rhoptry
organelles in P. falciparum.2. Results
2.1. Cloning and expression analysis of the mu subunit of the P. falciparum
AP-1 complex
To get insight into the role of theAP-1 complex in erythrocytic stages
of the malaria parasite, we cloned a C-terminal fragment of Pfμ1 (277–
437aa) with Plasmodb gene ID PF3D7_1311400, and expressed it in
E. coli. The recombinant protein was purified by affinity chromatogra-
phy, as shown in Fig. 1A. We raised antibodies in mice and rats against
the purified recombinant Pfμ1c protein. The specificity of the anti-
Pfμ1c antibody was assessed by western blot analysis of P. falciparum
strain 3D7 parasite lysate. As shown in Fig. 1B, anti-Pfμ1c antibody was
able to detect the full length Pfμ1 protein band of ~50 kDa in 3D7 lysate,
the size of the band corresponding to the size of native Pfμ1. Immunolo-
calization studies using anti-Pfμ1c antibodies at asexual blood stages of
the parasite showed well-defined punctate structures in schizont
stage of the parasite, a pattern characteristic of staining for apical secre-
tory organelles (Fig. 1C). These results demonstrate the specificity and
reactivity of the anti-Pfμ1c antibodies raised in the present study.
2.2. Generation of a chimeric GFP line and sub-cellular localization of Pfμ1
throughout the intraerythrocytic lifecycle of P. falciparum
To study the localization of the P. falciparum AP-1 complex and
elucidate its role in protein trafficking within the parasite, a transgenic
parasite line expressing the AP subunit Pfμ1 as a chimeric protein,
C-terminally taggedwithGFP, was generated. Fig. 2A shows a schematic
of the fusion construct used for transfection. Expression of the fusion
protein was confirmed by western blot analysis and fluorescence
microscopy. A western blot of transgenic parasite lysate was stained
using either anti-GFP or α-Pfμ1c antibodies. The anti-GFP antibody
detected a ~76 kDa band, corresponding to the expected size of the
GFP fusion construct in transgenic, but not 3D7, lysate (Fig. 2Bi). The
α-Pfμ1c antibody recognized two bands in the transgenic line; one cor-
responding to the GFP fusion protein and the other to the native Pfμ1
protein (Fig. 2Bii, lane 2). Staining of 3D7 lysate usingα-Pfμ1c antibody
detected only the native Pfμ1 protein (Fig. 2Bii, lane 1). Fig. 2B iii shows
loading control lanes probed by an ER resident protein PfBiP (~70 kDa)
We investigated the subcellular localization of Pfμ1–GFP by fluores-
cence microscopy of live cells at various time points throughout the
intracellular lifecycle. In early asexual blood stages, 10–18 h post-
invasion, Pfμ1–GFP was observed as a single spot in a small compart-
ment in close proximity to the nucleus (Fig. 2Ci). After further develop-
ment, in young trophozoite stages (20–24 h post invasion), two to four
fluorescent puncta were observed adjacent to the nucleus (Fig. 2Cii–iv).
As nuclear division commences (~32 h post invasion), Pfμ1–GFP was
localized in multiple compartments, ensuring that each merozoite
inherits one such spot (Fig. 2Cv). At the mature schizont stage, a well-
defined punctate staining was seen, typical of apical organelle distribu-
tion of proteins in Plasmodium (Fig. 2Cvi).
2.3. Pfμ1 resides near the Golgi compartment and is involved in post-Golgi
trafficking in early trophozoites
Localization of Pfμ1–GFP to a single loci adjacent to thenucleus in early
(10–18 h post invasion) stages of parasite development suggested its as-
sociationwith a single compartment. In order to define this compartment,
we performed immunofluorescence assays to stain for Pfμ1–GFP, as
well as the ER marker binding immunoglobulin protein (BiP) and a
Golgi marker Golgi re-assembly stacking protein (GRASP). As shown in
Fig. 3A & B, Pfμ1 partially co-localized with PfGRASP and PfBip, showing
very similar correlation coefficientswith eachmarker (~0.56). As detailed
in previous EM studies (e.g. [14]), the ER (which is contiguous with the
nuclear envelope) and Golgi in developing merozoites are very closely
juxtaposed, and dense vesicular traffic occurs between these two
Fig. 1. Expression and localization of Pfμ1 protein in P. falciparum. (A) Purified recombinant Pfμ1c protein, showing a band of expected size at ~20 kDa. (B) Immunoblot analysis of whole
cell 3D7 strain parasite lysate using antibodies raised against Pfμ1, demonstrating detection of a single ~50 kDa band corresponding to the native Pfμ1 protein. (C) Immunofluorescence
analysis using the anti-Pfμ1 antibody, demonstrating discreet punctate structures in schizont stage parasites. Parasite nuclei were stained with DAPI; scale bars denote 5 μm.
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analyzed the localization of Pfμ1–GFP with respect to PfRab7, amarker
for the recently described endosome in P. falciparum using anti-PfRab7
antibody. We failed to observe any overlap between the two proteins.
This suggests that Pfμ1–GFP and Rab7 do not co-localize, and hence that
Rab7 is not involved in trafficking at this stage (Figs. 3C and S1). These re-
sults thus suggest the presence of Pfμ1 in the Golgi–ER network during
the early stages of intra-erythrocytic development.
Brefeldin A is a fungalmetabolite that affects the GDP–GTP exchange
factors of the ARF family of small GTPases. AP-1, as well as AP-3 and
AP-4 have been shown to be sensitive to treatment with brefeldin A in
model systems, and so we sought to identify whether Plasmodium AP-
1 was also affected [17,29,30]. Therefore, we tested the effect of BFA
addition on the distribution of Pfμ1–GFP in transgenic parasites. After
16 h treatment with 5 μg/mL BFA, Pfμ1 exhibited a diffused staining
(Fig. 4A) in comparison to the control parasites wherein staining was
confined to well defined punctate structures in close association with
the parasite nuclei (Fig. 4B). To further characterize the effect of BFA
treatment on the localization of Pfμ1, we performed co-localization
studies with antibodies to ERD2 (a cis-Golgi marker) and BiP, as well
as the resident rhoptry protein RAP1 and the cytosolic protein Sel2.
Pfμ1 did not appear to show a similar pattern as Bip or Sel2, beyond
the overlap expected in a cell of this size. However, Pfμ1 showed a sub-
stantially similar staining pattern as ERD2 which is a Golgi marker that
has been previously shown to get re-distributed upon BFA addition [31]
(Fig. 4Ci–iii). Pfμ1 also did co-localizewith RAP1 in BFA treated parasites
(Fig. 4Civ). These observations are consistent with Pfμ1 being Golgi
associated at this life stage, consistentwith its similar dynamics of redis-
tribution upon brefeldin treatment
2.4. Pfμ1 co-localizes with resident rhoptry proteins in schizonts
Localization of punctate staining in the apical end of the parasite at
the late schizont stage suggested a role of Pfμ1 in trafficking to the apical
organelles. To further characterize the potential targets of Pfμ1 mediat-
ed trafficking events, we performed IFA with antibodies to rhoptry(RAP1 and Clag3.1), microneme (EBA175), and surface markers
(MSP1). IFAwith anti-MSP1 antibody showed nooverlap in staining be-
tweenMSP1 and Pfμ1 (Fig. 5A). Similar results were seen with antibod-
ies to EBA175 (Fig. 5B). Importantly, anti-RAP1 and anti-Clag3.1 showed
co-localizationwith the Pfμ1–GFP chimeric protein (Fig. 5C and D), sug-
gesting a potential role for Pfμ1 in rhoptry trafficking. These resultswere
confirmed using anti-RAP1 and anti-Pfμ1 antibodies (Figs. S2 and S3).
Co-localization between Pfμ1 and RAP1 was first observed ~24 h post
invasion in budding vesicles near the Golgi. As nuclear division com-
menced (32 h), Golgi multiplication occurred as well, and this resulted
in apical distribution of Pfμ1 alongwith RAP1 in the rhoptries. Two con-
focal imagery based movies of merozoites (Movie S1) and schizonts
(Movie S2) showing co-localization of Pfμ1 and RAP1 have been
uploaded with this manuscript. The co-localization between rhoptry
proteins and Pfμ1 was further quantified by Pearson's correlation co-
efficient analysis. Substantial correlation was observed between
Pfμ1, and both RAP1 (Figs. 5C and S4) and Clag3.1 (Fig. 5D). Addition-
ally, we performed co-immunoprecipitation (IP) studies pulling
down with antibodies against RAP1 and Pfμ1 (Fig. 6A). Immunopre-
cipitation using anti-RAP1, followed by incubation with anti-Pfμ1
showed two bands at ~50 and ~70 kDa, corresponding to the size
of the native and GFP-tagged Pfμ1 proteins in the transgenic para-
sites (Fig. 6A). Similarly, immunoprecipitation using anti-Pfμ1
allowed detection of the ~90 kDa native RAP1 protein, suggesting
that Pfμ1 and PfRap1 interact (Fig. 6A). In addition, we carried out
immuno-precipitation using anti-GFP antibody and transgenic para-
sites followed by LC/MS/MS analysis; a number of adaptin complex
proteins, clathrin and rhoptry proteins were identified in the sample
(Table S1). Our data thus demonstrates the spatiotemporal relation-
ship of Pfμ1 with immature and mature rhoptries, suggesting a role
for the AP-1 complex in association with the rhoptries.
2.5. Pfμ1 localization to rhoptries is dependent on vesicular trafficking
Though our localization studies demonstrate Pfμ1 in close association
with the rhoptry organelles in the late trophozoite/schizont stages of the
Fig. 2. Localization of Pfμ1 in different intracellular stages of P. falciparum. (A) Schematic diagram of thewild type Pfμ1 (PF3D7_1311400) showing location ofβ-binding domain and cargo-
binding domain. The complete gene was cloned in frame with GFP in the pARL1a + vector under the control of chloroquine resistant transporter gene promoter (crt 5′ UTR) and dhfr
terminator (3′ UTR). (B i) Immunoblot analysis of whole cell lysates of trophozoite-stage 3D7 and transgenic parasites expressing Pfμ1–GFP by α-GFP antibody shows a band at
~76 kDa. (B ii) Immunoblot analysis of whole cell lysates of trophozoite-stage 3D7 and transgenic parasites expressing Pfμ1–GFP by α-Pfμ1 antibody. A band at ~50 kDa, representing
the native protein is recognized by the Pfμ1 antibody in lanes 1 and 2, while another band at ~76 kDa (lane 2), representing the Pfμ1–GFP fusion, was recognized in the transgenic line
only. (B iii) Loading control lane as probed by anti-Pf BiP. (C) Live cell imaging of transgenic parasites expressing the Pfμ1–GFP fusion protein from early trophozoite to late schizont stages.
Parasite nuclei were stained with DAPI; scale bars denote 5 μM. ET, Early Trophozoite; MT, Mid Trophozoite; LT, Late Trophozoite; ES, Early Schizont; LS, Late Schizont.
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protein at these stages. To address this question, we utilized AlF4 treat-
ment, which functions as a general blocker of vesicular trafficking, i.e., it
inhibits intra-Golgi transport as well as anterograde cargo trafficking be-
tweenERandGolgi [32]. As shown in Fig. 6B, control trophozoites showed
typical ER–Golgi distribution for Pfμ1 as evident from its partial co-
localization with PfBip and PfGRASP markers. After AlF4 treatment, Pfμ1
labelingwas restricted to a small compartment,which appeared by corre-
lation analysis to be more closely associated with the parasite ER. This
drastic redistribution, demonstrated in the inset micrographs and sup-
ported by quantification, demonstrates the reliance of Pfμ1 localizationon proper vesicular trafficking in early development stages (Fig. S5A
and B). Together with the observation that Pfμ1–GFP redistributes upon
BFA addition, these results argue against a role for Pfμ1 as a resident pro-
tein at any stage, and suggest that its localization is dependent on vesicu-
lar traffic. This further suggests that the eventual rhoptry localization of
Pfμ1 is a direct result of post-Golgi Pfμ1-mediated trafficking of rhoptry
proteins. Confocal imagery-based movies of trophozoites showing co-
localization of Pfμ1 (Green) and PfBip (Red) before and after AlF4 treat-
ment (supplementary movies S3 and S4) along with movies S5 and S6
showing co-localization of Pfμ1 (Green) and PfGRASP (Red) before and
after AlF4 treatment have been uploaded with this manuscript.
Fig. 3. Pfμ1 is closely associated with the Golgi and ER in early trophozoite stages. Transgenic parasites expressing Pfμ1–GFP protein at trophozoite stages were immunostainedwith anti-
PfGRASP (A), anti-PfBiP (B) and anti-PfRab7 (C) antibodies. Theparasite nucleiwere stainedwithDAPI and slideswere visualized by confocal laser scanningmicroscopy. Values in brackets
show Pearson correlation coefficients; scale bars denote 5 μm.
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Though numerous studies to date have implicated the role of various
trafficking components in trafficking to the apical organelles, including
dynamin-like proteins [8], Rabs [9], and trans-membrane cargo recep-
tors [10], much remains to be deciphered about these critical processes.
One of the main questions is how post-Golgi cargo sorting and coat re-
cruitment are involved in the specificity of trafficking to the rhoptries,
and distinct sub-populations of micronemes. A previous study sug-
gested the role of AP-1 in trafficking to the rhoptries, but determining
the full extent of AP-1 involvement in the process was hampered bythe later discovery that TgROP2 does not possess a transmembrane do-
main, and hence cannot interact directly with the AP-1 mu subunit as
the author's claimed [26]. However, this early study did provide con-
vincing immunofluorescence and immuno-EM data for the localization
of Tgμ1 to post-Golgi vesicles, immature, and mature rhoptries as well
as direct functional data from disruption of AP-1 function through
point mutations and gene disruption. Additionally, immunoprecipita-
tion experiments with TgSORTLR revealed interactions with AP1 sub-
units and clathrin, suggesting that this interaction may be important
for the forward translocation of soluble rhoptry cargo [10], at least in
Toxoplasma. More recent immunolocalization data not only confirms
Fig. 4. Brefeldin A treatment disrupts Golgi localization of Pfμ1. Transgenic parasites expressing Pfμ1–GFP were treated with Brefeldin-A (at 5 μg/ml), or DMSO alone (control). Live cell
imaging of BFA-treated (A) or DMSO-treated (B) transgenic parasites at trophozoite stage after the treatment. (C) Transgenic parasites expressing Pfμ1–GFP were treated with Brefeldin
A (BFA) and immunostained with antibodies specific to cis-Golgi apparatus marker ERD2 (i), endoplasmic reticulum marker, Bip (ii), cytoplasm localized, Sel2 (iii) and RAP1 (iv). The
Pfμ1–GFP fusion protein colocalized with Sel2 as well as ERD2 in the parasite cytoplasm upon BFA treatment [C (i & iii)]. Parasite nuclei were stained with DAPI; scale bars denote 5 μm.
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Fig. 5. Pfμ1 co-localizeswith rhoptrymarker proteins in schizont stage parasites. Transgenic parasites expressing Pfμ1–GFPwere immunostainedwith antibodies specific to theMerozoite
surface localized MSP1 (A), Microneme localized EBA175 (B), and Rhoptry localized RAP1 (C) and Clag3.1 (D). The parasite nuclei were stained with DAPI and slides were visualized by
confocalmicroscopy. Representative images are shown for each antibody, together with DIC images; scale bars denote 5 μM. To quantify co-localisation, Pearson correlation coefficients of
the individual stains were calculated and are shown in the right panel of each image.
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ment of the retromer complex in this process, as TgSORTLR exhibits
similar co-localization with the apicomplexan homolog of Vps26 [5]. A
recent study in P. falciparummay tie these observations together with
our own. The authors describe an endosome-like compartment ([15]
and Fig. 7), adjacent to, but distinct from the ER and Golgi, which stains
positive for Rab7 and components of retromer, and suggest that vesicu-
lar traffic may occur through this organelle.
Surprisingly, we did not detect co-localization of Pfμ1–GFP with
Rab7 in our analyses. Instead, we observed Rab7 localization in other
parts of the infected cell, possibly coincident with the digestive vacuole,
which is a lysosome-like organelle. It is possible that Rab7 is involved in
diverse trafficking processes throughout the intracellular cycle, such
that we were unable to observe cells in which Pfμ1–GFP and Rab7 are
acting at similar steps. Further work will be required to clarify the role
of Rab7 and the retromer complex in trafficking to apical organelles in
Plasmodium. Our data are, however, consistent with the notion that
AP-1 is likely involved in rhoptry biogenesis and trafficking of proteins
to mature rhoptries in Plasmodium (Fig. 7). Pfμ1–GFP localizes to struc-
tures consistent with the Golgi apparatus in early trophozoite stages,
before rhoptries begin to form, and this interaction is sensitive to treat-
mentwith BFA. Rhoptry biogenesis begins roughly halfway through the
intracellular stage, and occurs via the fusion of specific Golgi-derived
vesicles, consistent with our localization data (Fig. 7A). As the intracel-
lular cycle progresses through late trophozoite and schizont stages,
Pfμ1–GFP localizes to distinct punctae at the apical end of developing
merozoites, consistent with rhoptry localization (Fig. 7B). Furthermore,
Pfμ1–GFP co-localizes with two resident rhoptry proteins, RAP1 and
Clag3.1, but not with known markers of micronemes (EBA-175) and
the parasite surface (MSP1). The incomplete nature of this co-localization may be explained by the presence of endosome-like com-
partments in close proximity to rhoptries in schizont stage parasites,
through which trafficking of rhoptry proteins may occur [15]. We dem-
onstrate a specific interaction between one of these proteins, RAP1, and
Pfμ1, consistentwith the notion that Pfμ1 is likely involved in trafficking
RAP1 to the rhoptries. Additionally, treatment with AlF4, which affects
Arf GTP exchange and acts to disturb normal trafficking processes, dis-
rupts established localization of Pfμ1, resulting in a punctate distribu-
tion. Previous studies have demonstrated fragmentation of the Golgi
upon AlF4 treatment, which is consistent with our observations [33].
Together, these results demonstrate sub-cellular localization for Pfμ1
consistent with a protein involved in rhoptry biogenesis and trafficking
throughout the intracellular lifecycle of P. falciparum, and suggest that
this localization is dependent on trafficking events.
We provide co-IP data demonstrating a weak but measurable inter-
action between RAP1 and Pfμ1. PfRAP1 does not contain putative trans-
membrane domains, which suggests that the interaction is not directly
mediated by any of the putative YXXϕ or LL motifs present in PfRAP1,
but occurs through at least one other protein in a complex. One poten-
tial identity for this protein is the P. falciparum homolog of TgSORTLR, as
it has been shown to interactwith clathrin and adaptor protein subunits
[10], but it is possible that other transmembrane cargo receptors could
be involved in trafficking tomicronemes and rhoptries in apicomplexan
parasites, and that escorter proteins such as RAMAmay also be involved
[34]. A recent analysis of clathrin function in T. gondii demonstrated that
functional ablation of clathrin caused defects in trafficking of the
microneme protein MIC3 and the rhoptry protein ROP5, as well as
affecting the morphology of the Golgi [35]. Their results are consis-
tent with clathrin being involved in post-Golgi trafficking, but they
could find no evidence of a role for clathrin in endocytosis, again
Fig. 6. Pfμ1 interacts with RAP1 in a trafficking-specific manner. (A) Immuno-precipitation of P. falciparum 3D7 schizont protein extracts was performed with anti-μ1 and anti-RAP-1
antibodies separately. The interaction of both the proteins was confirmed with western blot. Immuno pull-down of schizont total protein lysate with anti-RAP1 antibody recognizes
twobands ofMu1 corresponding to amolecularweight of 70 and 55 kDa,while immunoprecipitationwith anti-PfMu1 antibody recognizedRap1 at a band of 90 kDa. The asterisk indicates
the heavy chain of IgG eluted from the antibody affinity beads. (B) P. falciparum 3D7 infected RBCs were treated with 100 μm AlCl3 and 30 mMNaF in RPMI for 1 h at 37 °C. The washed
parasiteswere then stainedwith anti-GFP antibody (green) and anti-PfBip antibody (red). The parasite nucleiwere stainedwithDAPI and slideswere visualized by confocal laser scanning
microscopy. Values in brackets show Pearson correlation coefficients; scale bars denote 5 μm.
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in Apicomplexa.
Our data thus provide evidence for the role of AP-1 in trafficking to the
rhoptry organelles of P. falciparum, a function which is likely conserved
with T. gondii, and potentially all other Apicomplexa. A previous study
demonstrated that AP-1 is universally conserved in Apicomplexa, sugges-
tive of a conserved and essential function [24]. Assuming that rhoptriesandmicronemes aremodified endolysosomal organelles as hypothesized,
one obvious additional candidate for mediating trafficking would be the
AP-3 complex. However, Babesia, Theileria, and Cryptosporidium lack all
subunits of this complex, suggesting that it does not provide a conserved
function in all Apicomplexa. Additionally, the presence of other lysosome-
like organelles, such as the T. gondii lytic vacuole [36], and the Plasmodium
digestive vacuole [37], provides a tantalizing prospect for the involvement
Fig. 7. Proposed model of Pfμ1-mediated rhoptry trafficking in P. falciparum. (A) Early in merozoite development, coated vesicles transport rhoptry proteins between the ER and Golgi, a
process that can be inhibited by addition of BFA/AlF4. Adaptor proteins are synthesized at the ER face and proceed to recognize cargo at the Golgi through transmembrane cargo adaptors.
(B) As development progresses, vesicular traffic, whichmay be clathrin-mediated (not shown), progresses from the Golgi to rhoptries. The cargomay change receptors and recycling can
occur via the retromer complex. (C) Enlargement of the vesicle boxed off in panel (B), showing the binding of AP-1 to soluble rhoptry cargoes through a transmembrane receptor, as de-
scribed in the text. A = apicoplast, APR = apical polar rings, G = Golgi apparatus, M = mitochondrion, Mi = microneme, N = nucleus, NRH = nascent rhoptry, PfE = Plasmodium
falciparum endosome, and Rh = rhoptry.
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Apicomplexa revealed that an inhibitor resulted in the complete absence
of the lytic vacuole in T. gondii, which could be partially mitigated bymu-
tations in AP-3β, suggesting that AP-3may play a role in trafficking to this
organelle [38]. These data have implications for post-Golgi trafficking, and
specifically adaptor protein function, in organisms possessing multiple
lysosome-related organelles. Apicomplexa may prove an interesting
model system to study these processes moving forward.
Our data suggest that AP-1 is not involved in trafficking to
micronemes, or at least that EBA175 trafficking is AP-1-independent.
It is now widely known that micronemes do not represent a homoge-
neous population, and that differentmicroneme proteins require differ-
ent trafficking pathways. AP-1may be involved in trafficking of a subset
of microneme proteins, though this remains to be tested. Alternatively,
or perhaps in conjunction, the AP-4 and/or AP-2 complexes represent
potential candidates for this role, as they are also universally conserved
in Apicomplexa.
In conclusion,we have provided data suggestive of a function for the
AP-1 complex in trafficking to the rhoptries in P. falciparum. Pfμ1–GFP
localizes to the Golgi in early trophozoite stages, an association which
is sensitive to BFA, and assumes an apical localization by schizont stages.
Pfμ1–GFP displays correlated co-localization with two resident rhoptry
proteins, but not with known markers for the micronemes or the
merozoite surface, and this interaction is dependent on trafficking
processes. Additionally, Pfμ1 displays a consistent interaction with
RAP1 via co-immunoprecipitation. This provides corroborating evi-
dence to the work in other experimentally tractable apicomplexan
model organisms. Though the exact mechanisms involved in these traf-
ficking events remain to be deciphered,mounting evidence should nowput some of the controversy to rest and support the hypothesis that
adaptor proteins, especially AP-1, do play important roles in trafficking
to the apical organelles of apicomplexan parasites.
4. Materials and methods
4.1. Parasite culture and transfection
P. falciparum strain 3D7 parasitesweremaintained in culture usingO
positive human RBCs (4% hematocrit) in RPMI 1640media (Invitrogen)
supplementedwith 10%Albumax (GibcoBRL) following standard proto-
cols [39]. To generate the transfection vector constructs, the full length
Pfμ1 gene (437aa) was amplified from genomic DNA using forward
primer 5′ Cg ggA TCC AgA TTA gAC AAA ATg gCA TgT ATA Ag 3′ and
reverse primer 5′ C CCT Agg ggA CAT TCT gAC CTg ATA gTC 3′. The am-
plified fragments were digested with BamH1 and AvrII and ligated into
the pHH2 vector [40] using the BglII and AvrII sites to place the gene in
frame with the 3′ appended mut2 eGFP sequence. The amplified Pfμ1
gene was sub-cloned into the XhoI site of the transfection vector
pARL1a [41] and analysed for correct orientation. Parasite cultures
were synchronized by two consecutive sorbitol treatments at 4-hour
intervals following previously described protocols [42]. Tightly synchro-
nized ring stage parasites were collected by centrifugation and washed
with incomplete cytomix [43]. 200 μl of these parasites was then resus-
pended in a solution containing 370 μl of incomplete cytomix and 30 μl
of Plasmid DNA (100 μg) and transfected by electroporation (310 V,
950 μF). After electroporation, parasites were immediately transferred
to 10 ml of pre-warmed complete culture medium supplemented
with 200 μl of uninfected RBCs. The transfected parasites were selected
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the human dhfr gene present in the plasmid [44].
4.2. Cloning and expression of recombinant Pfμ1 protein and generation of
polyclonal anti-sera
The C-terminal fragment of the Pfμ1 gene was PCR amplified
from P. falciparum genomic DNA using forward primer 5′ CCC ATg
ggA TCC ACg TAT CgT CTA AgT ACT CAT g 3′) and reverse primer 5′
gC gTC gAC ggA CAT TCT gAC CTg ATA gTC 3′. The amplified PCR
products were ligated into the pET28a vector (Novagen) using the
NcoI and SalI sites. The expression construct was transformed into
expression cells BL21 (DE3) which were grown in Luria broth con-
taining kanamycin (25 μg/ml) at 37 °C in a shaking rotor and in-
duced with isopropyl-β-thiogalactopyranoside (IPTG) at 1 mM
final concentration. The cultures were further grown at 37 °C for
4 h and the E. coli cells were harvested by centrifugation. The cell
pellet was suspended in lysis buffer (20 mM Tris pH 8.0, 500 mM
NaCl, 1 mM phenyl methyl sulphonyl flouride, and 1% Tween 20),
and the bacterial cells were lysed by sonication (Torebeo Ultrasonic
Processor 36800, Cole Parmer). The lysate was centrifuged at
15,000 ×g for 30 min at 4 °C, and the supernatant was discarded.
The pellet was dissolved in 8 M urea (50 mM Tris pH 8.0, 300 mM
NaCl) and incubated with Ninitrilotriacetic acid (Ni2+-NTA) agarose
resin (Qiagen), pre-equilibrated with 8 M urea buffer pH 8.0, at
room temperature for 1 h. The suspension was applied to a column
and washed with 10 bed volumes of the wash buffer (8 M urea pH 8.0,
50 mM Tris, 300 mM NaCl). The bound protein was eluted with 10 bed
volumes of elution buffer containing between 50 and 500 mM imidazole
gradient (8 M urea pH 8.0 in 50mM Tris, 300mMNaCl). The eluted frac-
tionswere analyzed onSDS-PAGEand the fractions containing the recom-
binant protein with a clear single band were pooled and dialysed to
remove imidazole and urea. The protein concentration was determined
using the bicinchoninic acid assay (BCA method) using a standard
curve of bovine serum albumin. Rat antiserum was raised against
the C-terminal end of Pfμ1 protein and the titre was measured
using ELISA.
4.3. Immunoflourescence and microscopy
Parasite fixation for indirect immunoflourescence assays and GFP
localization was performed as described previously [45]. Briefly, thin
smears of P. falciparum iRBCs were made on glass slides, and subse-
quently washed and fixed with fixation solution containing 4% parafor-
maldehyde and 0.0075% glutaraldehyde in PBS for 30 min. After
washing with PBS, slides were subjected to permeabilization with 0.1%
Triton X-100 and treated with 0.1 mg/ml NaBH4 to remove free alde-
hyde groups; each for 10 min. Parasites on slides and in solution were
blocked using 3% BSA in PBS for 1 h. After blocking, slides were incubat-
ed with appropriate primary antibodies (Rat anti-μ1 1:100, other anti-
bodies 1:250 for 1 h at 37 °C). After proper washing with PBS, slides
were incubated with appropriate secondary antibodies conjugated to
fluorescent dye (FITC 1: 250 or Cy3 1:500) for 1 h at 37 °C. Incubation
with DAPI (2 μg/ml for 30 min at 37 °C) was used to stain the nucleus.
After 3 consecutive 1 × PBS washes, slides were mounted with
cover slips in the presence of anti-fade mounting media (Bio-Rad).
The stained 3D7 and transgenic parasites were imaged on a Nikon
TE 2000-U fluorescence microscope. The images were analyzed by
NIS elements software (Nikon).
4.4. Western blotting
For the western blot analyses, 3D7 and Pfμ1–GFP transgenic par-
asites were isolated from tightly synchronized cultures at schizont
stage by lysis of iRBCs with 0.15% saponin. Parasite pellets were
washed with PBS, suspended in 4% SDS sample buffer containingβ-mercaptoethanol, boiled, and centrifuged, and the supernatant
obtained was separated on a 12% SDS–PAGE gel. The fractionated
proteins were transferred from gel onto a high-protein-binding-
capacity hydrophobic polyvinylidene difluoride (PVDF) membrane
(Amersham) and blocked in blocking buffer (1% PBS, 0.1% Tween-20, 3%
BSA) for 2 h. The blotwaswashed and incubated for 1 hwith primary an-
tibody (Rat anti-Pfμ1 1:250; rabbit anti-GFP 1:500) diluted in dilution
buffer (1X PBS, 0.1% Tween-20, and 1% BSA). Later, the blot was washed
and incubated for 1 h with appropriate secondary antibody (anti-mice,
rat or rabbit antibodies 1:3000) conjugated to HRP, diluted in dilution
buffer. Bandswere visualized by using the ECL detection kit (Amersham).
4.5. Brefeldin A treatment
Parasite cultures were treated using Brefeldin A (BFA) following the
procedure described in a previous study [46]. Briefly, P. falciparum
cultures were synchronized by two consecutive sorbitol treatments at
4 hour intervals and cultured further for 40 h and allowed to re-
invade. Brefeldin A was added to the culture at a concentration of
5 μg/ml from a stock solution of 10 mg/ml BFA in DMSO; a control cul-
ture was maintained using the equivalent amount of DMSO to ensure
the solvent had no effect on growth or cell morphology. After 16 h,
BFA was removed from culture by washing twice and the parasites
were cultured for another 24 h in BFA free media to ensure viability of
cells after BFA treatment.
4.6. Co-immuno-precipitation
Infected erythrocytes containing late stage P. falciparum (40–42 h
post-infection) were harvested by centrifuging at 2000 rpm for 5 min
and treated with 1.5 vol 0.15% saponin (in PBS) for 10 min at 4 °C.
Cells were again centrifuged at 7000 rpm for 15 min to separate intact
parasites from the lysed erythrocytes. The parasite pellet was washed
several timeswith PBS. Parasite lysatewas prepared by treating the pel-
let with IP Lysis Buffer (provided with the Pierce Crosslink Immunopre-
cipitation Kit-Product #26147) containing protease inhibitors, for 15–
20 min at 4 °C with intermittent mixing. Released cellular contents
were separated from the debris by centrifugation at 13,000 rpm for
20 min. Total protein content of the lysate was determined by the BCA
Protein estimation assay kit (Pierce). The co-immunoprecipitation ex-
periments were carried out according to the manufacturer's instruc-
tions. Briefly, 1 mg of total protein was incubated overnight at 4 °C
with 10 μg of anti-Pfμ1 (Rat) and/or anti-PfRap1 (Mouse) antibodies
cross-linked to 10 μl of Protein A/G sepharose beads. An equal amount
of protein was allowed to interact with beads conjugated and cross-
linked to pre-immunemouse or rat sera to serve as a control. After bind-
ing, beads were washed with the Wash Buffer and the bound proteins
were eluted from the beads using the Elution Buffer. The elutes were
used to perform the immune-blotting using anti-PfRap-1 and anti-
Pfμ1 antibodies.
4.7. AlF4 treatment
Parasite cultures were treated using AlF4, as described previously
[47]. Briefly, P. falciparum 3D7 iRBCs were treated with 100 μm AlCl3
and 30 mM NaF in RPMI for 1 h at 37 °C. The RBCs were then washed
thrice by iRPMI and smears were prepared for confocal microscopy, as
described under “Immunofluorescence and microscopy”.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.12.030.
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